NVIV
InVivo Therapeutics Holdings Corp
NVIV
NVIV
Delisted
NVIV was delisted on the 12th of February, 2024.
45 hedge funds and large institutions have $50.4M invested in InVivo Therapeutics Holdings Corp in 2016 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
64% less call options, than puts
Call options by funds: $255K | Put options by funds: $712K
Holders
45
Holding in Top 10
1
Calls
$255K
Puts
$712K
Top Buyers
| 1 | +$1.21M | |
| 2 | +$757K | |
| 3 | +$700K | |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$386K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$379K |
Top Sellers
| 1 | -$3.35M | |
| 2 | -$867K | |
| 3 | -$152K | |
| 4 |
LPL Financial
San Diego,
California
|
-$133K |
| 5 |
Morgan Stanley
New York
|
-$131K |